At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 55 enrolled
Drug / intervention
High Dose Device +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of a Glaucoma Drug Delivery System
In Brief
A Phase 2 clinical trial evaluating High Dose Device, Low Dose Device, and 1 other intervention for Glaucoma, Open-Angle and Ocular Hypertension. Completed, enrolled 55 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open-Angle, Ocular Hypertension
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
First PostedJan 2009
Primary CompletionApr 2009
TodayJul 2026
First PostedJan 19, 2009
Enrollment StartDec 1, 2008
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.5 years ago
Interventions
High Dose Devicedrug
inserted for 14 days
Low Dose Devicedrug
inserted for 14 days
Placebo Devicedevice
inserted for 14 days